retatrutide phase 2 results 2024 2025 press release Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first 3 trial for treatment of type diabetes What Is Retatrutide? Side Effects,
Pay in 4 interest-free payments of $5.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2


























